Average Co-Inventor Count = 7.39
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Medivir Ab (12 from 120 patents)
2. Tibotec Pharmaceuticals Ltd. (10 from 66 patents)
3. Janssen Sciences Ireland Uc (7 from 111 patents)
4. Janssen R&d Ireland (6 from 45 patents)
5. Medivar Ab (2 from 2 patents)
6. Tibotec Bvba (1 from 13 patents)
7. Tibotec-virco Virology Bvba (1 from 2 patents)
8. Tibotec Pharmaceuticals Ltd. Co (1 from 1 patent)
26 patents:
1. 9987277 - Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C
2. 9951075 - Pteridines useful as HCV inhibitors and methods for the preparation thereof
3. 9856265 - Macrocyclic inhibitors of hepatitis C virus
4. 9708328 - Pteridines useful as HCV inhibitors and methods for the preparation thereof
5. 9623022 - Macrocyclic inhibitors of hepatitis C virus
6. 9353103 - Macrocyclic inhibitors of hepatitis C virus
7. 9290502 - Pteridines useful as HCV inhibitors and methods for the preparation thereof
8. 9040562 - Macrocyclic inhibitors of hepatitis C virus
9. 9023808 - Macrocyclic inhibitors of hepatitis C virus
10. 8754105 - Macrocyclic inhibitors of hepatitis C virus
11. 8754106 - Macrocyclic inhibitors of hepatitis C virus
12. 8754116 - Macrocyclic inhibitors of hepatitis C virus
13. 8741926 - Macrocyclic inhibitors of hepatitis C virus
14. 8349869 - Macrocylic inhibitors of hepatitis C virus
15. 8227407 - Macrocyclic inhibitors of hepatitis C virus